In Depth Analysis of PEGylated Protein Therapeutics Market to Witness a Pronounce Growth During 2018-2025
According to a new report
published by KD Market Insights, titled, " PEGylated Protein Therapeutics
Market by Product Type, Application, and Sales Channel: Global
Opportunity Analysis and Industry Forecast, 2018-2025, the market was valued at
$10,388 million in 2017, and is projected to reach $17,813 million by 2025,
growing at a CAGR of 6.9% from 2018 to 2025. North America is
anticipated to be the highest revenue contributor throughout the forecast
period.
PEGylation is a process of
addition of active polyethylene glycol (PEG) to different forms of therapeutic
proteins for chemical modification. These chemically modified therapeutic
proteins are called PEGylated protein therapeutics. The chemical modification
due to PEGylation results in various advantages, such as an extended half-life
of a drug along with low toxicity and increased proteolytic protection, over
the non-modified protein therapeutics. PEGylated protein therapeutics are used
in multiple conditions such as cancer, hemophilia, rheumatoid arthritis,
ankylosing spondylitis, Crohns disease, and others.
The factors that drive the
growth of the global PEGylated protein therapeutics market are increase in
prevalence of chronic diseases, advantages offered by PEGylation, and strong
presence of pipe line drugs are. However, high cost related to drug development
and launch of generics during the forecast period are expected to impede the
market growth. In addition, high market potential in the untapped emerging
economies and increase in adoption of PEGylated protein therapeutics are
expected to provide many opportunities during the forecast period.
By product type, the
colony stimulating factor segment accounted for nearly half share of the global
occupational medicine market in 2017. Furthermore, the cancer segment is
anticipated to grow at the highest rate of 7.4% during the forecast period.
Key Findings of the
PEGylated Protein Therapeutics Market:
- North America occupied
nearly two-thirds share of the global PEGylated protein therapeutics market in
2017
- The cancer segment is anticipated to grow with the highest CAGR throughout the forecast period.
- Europe is anticipated to occupy one-fifth market share of the global PEGylated protein therapeutics market by 2025.
- Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.
- The cancer segment is anticipated to grow with the highest CAGR throughout the forecast period.
- Europe is anticipated to occupy one-fifth market share of the global PEGylated protein therapeutics market by 2025.
- Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.
Browse Full Report
& TOC: https://www.kdmarketinsights.com/product/pegylated-protein-therapeutics-market-amr
North America was the
leading revenue contributor to the global market in 2017, owing to FDA approval
and launch of new drugs in this region. However, Asia-Pacific is expected to
grow at the highest CAGR of 7.4% from 2018 to 2025, due to increase in
affordability, surge in healthcare expenditure, and rise in awareness toward
chronic disorders.
The report provides an
extensive competitive analysis and profiles of the key market players such as
Amgen Inc., AstraZeneca PLC, Biogen, Inc., F. Hoffmann-La Roche Ltd.
(Genentech, Inc.,), Horizon Pharma plc., Leadiant Biosciences S.p.A., Merck
& Co., Inc. (Schering-Plough Corporation), Pfizer Inc., Shire plc
(Baxalta), and UCB S.A.
About Us:
KD Market Insights offers a comprehensive database of syndicated
research studies, customized reports, and consulting services. These reports
are created to help in making smart, instant and crucial decisions based on
extensive and in-depth quantitative information, supported by extensive
analysis and industry insights.
Our dedicated in-house team ensures the reports satisfy the requirement
of the client. We aim at providing value service to our clients. Our reports
are backed by extensive industry coverage and is made sure to give importance
to the specific needs of our clients. The main idea is to enable our clients to
make an informed decision, by keeping them and ourselves up to date with the
latest trends in the market.
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
Telephone: +1 (516) 300-1215
Comments
Post a Comment